COPD affects worker productivity and health care costs

Area of Science:

• Health Economics
• Pulmonology
• Public Health

Background:

• Chronic obstructive pulmonary disease (COPD) represents a significant global health challenge.
• Understanding the economic burden of COPD is crucial for resource allocation and healthcare policy.
• Previous estimates may not fully capture the true costs, including indirect economic impacts.

Purpose of the Study:

• To quantify the incremental direct and indirect costs associated with COPD in working-age adults.
• To evaluate direct medical resource utilization and productivity metrics in COPD patients.
• To assess COPD-specific resource use and associated costs.

Main Methods:

• A retrospective, observational, matched cohort study design was employed.
• Administrative claims data from Truven Health MarketScan databases (2007-2010) were utilized.
• Working-age patients (18-65 years) with and without COPD were identified and compared based on healthcare utilization and diagnosis.

Main Results:

• The incremental direct cost of COPD was estimated at $6,246 per patient per year compared to non-COPD patients.
• Patients with COPD experienced an average of 5 more days of absence from work annually, with incremental indirect costs of $641 from short-term disability.
• Direct costs were substantially higher for frequent ($17,651/year) and infrequent ($14,501/year) exacerbators compared to non-exacerbators ($11,395/year).

Conclusions:

• Working-age individuals with COPD incur significantly higher direct medical costs and indirect costs related to productivity loss.
• COPD patients utilize more healthcare resources compared to their non-COPD counterparts.
• These findings underscore the substantial economic burden of COPD on individuals and society.